We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABTC
4551
American Bitcoin Corp
ABTC
$403M
-1
Closed -$125K
PAMT
4552
PAMT Corp
PAMT
$337M
$12K ﹤0.01%
944
-5,092
-84% -$73.8K
CWBR
4553
DELISTED
CohBar, Inc. Common Stock
CWBR
$12K ﹤0.01%
297
-669
-69% -$26.2K
CIZN
4554
DELISTED
Citizens Holding Co.
CIZN
$12K ﹤0.01%
662
-3,253
-83% -$62.3K
CEMI
4555
DELISTED
Chembio diagnostics, Inc.
CEMI
$12K ﹤0.01%
4,257
-12,259
-74% -$42.7K
ATXS
4556
DELISTED
Astria Therapeutics
ATXS
$11K ﹤0.01%
885
-5,269
-86% -$68.4K
AUBN icon
4557
Auburn National Bancorp
AUBN
$91.3M
$11K ﹤0.01%
291
-1,664
-85% -$61.1K
ERTH icon
4558
Invesco MSCI Sustainable Future ETF
ERTH
$133M
$11K ﹤0.01%
+166
New +$12.2K
GIGM icon
4559
GigaMedia
GIGM
$15.7M
$11K ﹤0.01%
3,644
INOD icon
4560
Innodata
INOD
$2.05B
$11K ﹤0.01%
1,613
+273
+20% +$1.85K
KORU icon
4561
Direxion Daily MSCI South Korea Bull 3X ETF
KORU
$1.12B
$11K ﹤0.01%
+488
New +$10.5K
NMR icon
4562
Nomura Holdings
NMR
$28.3B
$11K ﹤0.01%
2,126
+1,700
+399% +$9.14K
NWE icon
4563
NorthWestern Energy
NWE
$4.23B
$11K ﹤0.01%
192
+152
+380% +$9.9K
PANL icon
4564
Pangaea Logistics
PANL
$498M
$11K ﹤0.01%
2,154
-6,684
-76% -$25.9K
SVM
4565
Silvercorp Metals
SVM
$2.07B
$11K ﹤0.01%
2,000
UMDD icon
4566
ProShares UltraPro MidCap400
UMDD
$31.8M
$11K ﹤0.01%
+340
New +$10.7K
SCTL
4567
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$11K ﹤0.01%
4,728
-11,475
-71% -$29.1K
NM
4568
DELISTED
Navios Maritime Holdings Inc.
NM
$11K ﹤0.01%
+1,174
New +$10.2K
SCPL
4569
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$11K ﹤0.01%
670
-130
-16% -$2.24K
APEN
4570
DELISTED
Apollo Endosurgery, Inc.
APEN
$11K ﹤0.01%
1,399
+900
+180% +$6.17K
HIL
4571
DELISTED
Hill International, Inc. Common Stock
HIL
$11K ﹤0.01%
4,243
+3,027
+249% +$8.07K
AIVL icon
4572
WisdomTree US AI Enhanced Value Fund
AIVL
$428M
$10K ﹤0.01%
+102
New +$9.98K
ANIX icon
4573
Anixa Biosciences
ANIX
$116M
$10K ﹤0.01%
2,532
-7,466
-75% -$31.8K
AP icon
4574
Ampco-Pittsburgh
AP
$163M
$10K ﹤0.01%
1,658
+1,368
+472% +$9.27K
ASYS icon
4575
Amtech Systems
ASYS
$268M
$10K ﹤0.01%
1,085
+1,070
+7,133% +$11K

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.